Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10172810 | 0.88 | NPSR1 (0.50) | NPSR1ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL10172812 | 0.85 | ALDH1A1 (0.51) | NPSR1ALDH1A1LMNATSHRABL1 | |
| SCHEMBL20008913 | 0.84 | NPSR1 (0.57) | NPSR1ALDH1A1LMNARXFP1TSHR | |
| SCHEMBL10172817 | 0.84 | ALDH1A1 (0.45) | NPSR1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL10172854 | 0.82 | ALDH1A1 (0.50) | NPSR1ALDH1A1LMNATSHRABL1 | |
| SCHEMBL16368851 | 0.80 | NPSR1 (0.60) | NPSR1ALDH1A1LMNARXFP1TSHR | |
| SCHEMBL10067116 | 0.80 | ALDH1A1 (0.44) | NPSR1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL14648938 | 0.80 | NPSR1 (0.45) | NPSR1ALDH1A1LMNARXFP1TSHR | |
| SCHEMBL12376743 | 0.79 | NPSR1 (0.42) | NPSR1ALDH1A1LMNARXFP1MEN1 | |
| SCHEMBL25844993 | 0.78 | NPSR1 (0.41) | NPSR1ALDH1A1LMNARXFP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | JSR CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | RAD51, RER1, ATP6AP1 | NPSR1 3120/4885ALDH1A1 1300/4885LMNA 3748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.